Author:
Grobbelaar Melanie,Louw Gail E.,Sampson Samantha L.,van Helden Paul D.,Donald Peter R.,Warren Robin M.
Funder
DST-NRF Centre of Excellence for Biomedical Tuberculosis Research
South African Medical Research Council Centre for Tuberculosis Research
Stellenbosch University Subcommittee C
Harry Crossley Foundation
South African Research Chairs Initiative of the Department of Science and Technology
National Research Foundation
Robert Bosch Stiftung
Subject
Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology
Reference119 articles.
1. Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 Milligrams daily in patients with pulmonary tuberculosis;Aarnoutse;Antimicrob. Agents Chemother.,2017
2. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis;Anastasatu;Scand. J. Respir. Dis. Suppl.,1973
3. Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany;Andres;Antimicrob. Agents Chemother.,2014
4. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis;Ängeby;Bull. World Health Organ.,2012
5. Rifampicin: a new rifamycin. I. Bacteriological studies;Arioli;Arzneimittelforschung,1967
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献